Procept outlines 2026 U.S. procedures of 54,000 to 56,000 while targeting positive adjusted EBITDA in Q4 2026 — See source for full details.
$PRCT
Price history, market instrument context, member research, and related headlines in one place.
PRCT key statistics
NasdaqGMUSD
52-week range
$16.674%$38.11
Latest session $17.49–$19.02PROCEPT BioRobotics Corporation (PRCT) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $17.51, down $1.59 (8.32%) from the previous close of $19.10. It has traded between $17.49 and $19.02 in the latest session. Over the past year it has ranged from $16.67 to $38.11, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 1.7M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $PRCT research…